Avatar photo

Ron Finklestien

Interesting BLMN Put And Call Options For January 2025

Investors in Bloomin’ Brands Inc (Symbol: BLMN) saw new options become available today, for the January 2025 expiration. One of the key inputs that ...

RSI Alert: DXC Technology (DXC) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try ...

Friday Sector Laggards: Entertainment, Trucking Stocks

In trading on Friday, entertainment shares were relative laggards, down on the day by about 1.1%. Helping drag down the group were shares of ...

iShares U.S. Real Estate ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares U.S. Real Estate ...

Wall Street Favorites: 3 REITs With Strong Buy Ratings for May 2024

Source: shutterstock.com/jaturonoofer When investors talk about gains in the stock market, we usually think of high-flying growth and tech stocks. Over a long enough ...

Interesting ROP Put And Call Options For July 19th

Investors in Roper Technologies Inc (Symbol: ROP) saw new options become available today, for the July 19th expiration. At Stock Options Channel, our YieldBoost ...

Assessing Target (TGT) Stock Ahead of Q1 Earnings Release

Target Corporation TGT is expected to report a decline in its top line when it announces first-quarter fiscal 2024 results on May 22, before ...

Friday's ETF with Unusual Volume: WTAI

The WisdomTree Artificial Intelligence and Innovation Fund ETF is seeing unusually high volume in afternoon trading Friday, with over 678,000 shares traded versus three ...

European Commodities: Cocoa Prices Are Crashing, But Not on Fundamentals

The impressive crash in Cocoa #7 (CAN24), which started on April 25, had certainly been anticipated on the first move below the 10-unit exponential ...

Amgen’s (AMGN) Tarlatamab Receives FDA Approval for SCLC

Amgen AMGN announced that the FDA has granted accelerated approval to tarlatamab for pre-treated advanced small cell lung cancer (ES-SCLC). Tarlatamab is a delta-like ligand ...